The legal context for partner notification varies within Europe due to diverse legal and policy frameworks, cultural influences and social factors. The report presents key findings and recommendations to improve partner notification methods across Europe.
This report from the ECDC country visit to Finland in October 2012 provides an overview of Finland’s national strategies and programmes for HIV and sexually transmitted diseases.
The sixth edition of the Annual Epidemiological Report on communicable diseases in Europe provides a comprehensive summary of surveillance data for 2010 and an analysis of the public health threats detected in 2011 through ECDC’s routine epidemic intelligence.
Following an invitation from Greek authorities, a team of experts from ECDC, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the WHO Regional Office for Europe visited Greece in May 2012.
This ECDC surveillance report on sexually transmitted infections (STI) in Europe covers 20 years of surveillance data collection and analyses the basic trends and epidemiological features of the five STI under EU surveillance: syphilis, congenital syphilis, gonorrhoea, chlamydia and lymphogranuloma venereum (LGV).
The human immunodeficiency virus (HIV) remains one of the most important communicable diseases in Europe. It is an infection associated with serious disease, persistently high costs of treatment and care, significant number of deaths and shortened life expectancy.
Since 2008, ECDC and the WHO Regional Office for Europe co-ordinate enhanced HIV/AIDS surveillance in Europe covering all 53 countries in the WHO European Region.
Cryptosporidia are intestinal parasites infecting a variety of animals (e.g. cattle, sheep, rodents, cats and dogs, but also birds, fish and reptiles). Human infections occur due to Cryptosporidium parvum, a species that also affects domestic animals.
Following a request by the Romanian government, ECDC conducted a second follow-up country visit to Romania covering HIV, sexually transmitted infections (STIs) and hepatitis B and C from 11–13 May 2011.